• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARROW INTERNATIONAL LLC ARROW REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARROW INTERNATIONAL LLC ARROW REDIGUARD IAB: 8FR 40CC; SYSTEM, BALLOON, INTRA-AORTIC Back to Search Results
Catalog Number IAB-S840C
Medical Device Problem Code Inflation Problem (1310)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/19/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).
 
Event or Problem Description
It was reported "after the catheter inserted, the balloon can not inflate completely, change the new catheter.".No patient injury or consequence reported.The patient's current condition is reported as "fine".
 
Additional Manufacturer Narrative
(b)(4).No serial number was reported.The serial number on the returned sample is (b)(6).Returned for investigation was a 40cc 8.0fr rediguard intra-aortic balloon catheter (iabc) with an original packaging box that matches the reported lot number.The sample was returned in a cardboard box and was loosely packed within the original packaging carton.Returned with the sample was the supplied 40cc inflation driveline tubing.The one-way valve was tethered to the short driveline tubing.The bladder was fully unwrapped.Kinks to the central lumen were noted at approximately 39.5cm and 41.7cm from the distal tip.Dried blood was noted on the exterior surfaces of the re-turned sample.No blood was noted within the bladder/helium pathway.The one-way valve was tested and passed.A vacuum was pulled on the one-way valve, and it held for at least 1 minute according to quality system document.An attempt to aspirate and flush the iabc central lumen using a 60cc lab-inventory syringe was unable to be successfully completed due to a blocked/ clotted central lumen.Upon aspiration, water was unable to be pulled into the syringe.Immediate push back on the syringe plunger was experienced.The blockage was most likely dried blood.The iabc was connected to an iabp using the returned 40cc inflation driveline tubing.The iabc was inserted into the "t" tube and 100mmhg backpressure was applied.The iabc was pumped for a minimum of 30 minutes.The bladder inflated and deflated completely with each beat.The balloon pressure waveform (bpw) was normal.The iabc was leak tested in accordance with testing methods from manufacturing procedure.No leaks were detected.Full inflation was achieved.The device passed the leak test.A lab inventory 0.025in guidewire was back loaded through iabc distal tip.The guidewire met resistance and could not advance at approximately 15.6cm from the distal tip.Some blood and debris was noted.The guidewire was front loaded through the iabc luer end.The guidewire met resistance and could not advance at approximately 28.3cm form the luer end.Some blood and debris was noted.A device history record (dhr) re-view was conducted for the lot number with no relevant findings.The device passed all manufac-turing specifications prior to release.The reported complaint for "the balloon can not inflate completely" is not confirmed.The re-turned intra-aortic balloon catheter (iabc) passed functional test specifications.The returned iabc bladder was fully intact with no abnormalities noted.During the investigation, the iabc fully inflated, and no leaks were detected.Based on a review of the device history record (dhr), the product met specification upon release.The root cause of the complaint is undetermined.No fur-ther action is required at this time.
 
Event or Problem Description
It was reported "after the catheter inserted, the balloon can not inflate completely, change the new catheter.".No patient injury or consequence reported.The patient's current condition is reported as "fine".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARROW REDIGUARD IAB: 8FR 40CC
Common Device Name
SYSTEM, BALLOON, INTRA-AORTIC
Manufacturer (Section D)
ARROW INTERNATIONAL LLC
morrisville NC
Manufacturer (Section G)
ARROW INTERNATIONAL INC.
16 elizabeth drive
chelmsford MA 01824
Manufacturer Contact
sachin sony
3015 carrington mill blvd
morrisville, NC 27560
MDR Report Key24322317
Report Number3010532612-2026-00129
Device Sequence Number21315012
Product Code DSP
UDI-Device Identifier10801902172065
UDI-Public(01)10801902172065(11)250228(17)270131(10)18F25B0103(21)
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K981660
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,User Facility
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 01/21/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Catalogue NumberIAB-S840C
Device Lot Number18F25B0103
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/03/2026
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/21/2026
Supplement Date Received by Manufacturer02/23/2026
Initial Report FDA Received Date02/12/2026
Supplement Report FDA Received Date03/03/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured02/28/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
N/A.; N/A.
Patient Age73 YR
Patient SexMale
-
-